Developing a new treatment for preeclampsia
Advancing a novel therapy for preeclampsia
This study is looking at a new way to help women with severe preeclampsia by testing a medication called Digibind to see if it can improve their health during pregnancy.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Larix Bioscience, LLC NIH-funded |
| Lab location | 1 site (Sunnyvale, United States) |
| Project ID | NIH-10478384 on NIH RePORTER |
What this research studies
This research focuses on creating a novel therapy for preeclampsia, a serious pregnancy complication characterized by high blood pressure and protein in the urine. The approach involves investigating the role of an endogenous substance known as marinobufagenin, which is believed to contribute to the condition. The study aims to evaluate the effectiveness of Digibind, an existing medication, in improving outcomes for patients with severe preeclampsia. By targeting the underlying mechanisms of the disease, the research hopes to provide a more effective treatment option for affected women.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant women diagnosed with severe preeclampsia.
Not a fit: Patients who are not pregnant or those with mild preeclampsia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new therapy that significantly improves the health outcomes for pregnant women suffering from preeclampsia.
How similar studies have performed: Previous clinical trials have shown promising results using similar approaches, indicating potential for success in this area.
Where this research is happening
Sunnyvale, United States
- Larix Bioscience, LLC — Sunnyvale, United States (Active)
Researchers
- Principal investigator: Yu, Bo — Larix Bioscience, LLC
- Study coordinator: Yu, Bo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.